Effect of culture supernatants from two cancer cell lines on healthy donors' monocytes
Background: it is well known that culture cells secrete to their medium different factors that can alter their own as well as other cells' metabolism and functions. In the present study we evaluated the effect of culture supernatants originated from two cancer cell lines, Calu-1 (lung epidermoi...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
1999
|
| Acceso en línea: | Registro en Scopus Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 09358caa a22009017a 4500 | ||
|---|---|---|---|
| 001 | PAPER-19538 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518205053.0 | ||
| 008 | 190411s1999 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-0033162341 | |
| 024 | 7 | |2 cas |a Culture Media, Conditioned; HLA-DR Antigens | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a AGIMB | ||
| 100 | 1 | |a Novellino, P.S. | |
| 245 | 1 | 0 | |a Effect of culture supernatants from two cancer cell lines on healthy donors' monocytes |
| 260 | |c 1999 | ||
| 270 | 1 | 0 | |m Rumi, L.S.; Inst. de Biol. y Med. Experimental, Vuelta de Obligado 2490, (1428) Buenos Aires, Argentina |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Graubert, T.A., Ley, T.J., How do lymphocytes kill tumor cells? (1996) Clin Cancer Res, 2, pp. 785-789 | ||
| 504 | |a Nathan, C.F., Secretory products of macrophages (1987) J Clin Invest, 79, pp. 319-326 | ||
| 504 | |a Vandernabeele, P., Declercq, W., Beyaert, R., Fiers, W., Two tumor necrosis factor receptors: Structure and function (1995) Trends in Cell Briol, 5, pp. 392-399 | ||
| 504 | |a Induction of apoptosis in mature T cells by tumor necrosis factor (1995) Nature, 377, pp. 348-351 | ||
| 504 | |a Baron, S., Tyring, S.T., Fleischmann, W.R., Coppenhaver, D.H., Nielsel, D.W., Kumpel, G.R., Stanton, J., Hughes, T.K., The interferons: Mechanisms of action and clinical applications (1991) JAMA, 266 (10), pp. 1375-1383 | ||
| 504 | |a Basham, T., Merigan, T.C., Recombinant interferon-γ increases HLA-DR synthesis and expression (1983) J Immunol, 130 (4), pp. 1492-1494 | ||
| 504 | |a Tilg, H., New insights into the mechanisms of interferon alfa: An immunoregulatory and anti-inflammatory cytokine (1997) Gastroenterol, 112, pp. 1017-1021 | ||
| 504 | |a Stuyf, S., Van Coillie, E., Paemen, L., Put, W., Lenaerts, J.P., Proost, P., Synergistic induction of MCP-1 and -2 by II-1β and interferons in fibroblasts and epitelial cells (1998) J Leuk Biol, 63 (3), pp. 364-372 | ||
| 504 | |a Giordano, L., Moldwin, R.L., Downie, P.A., Goldberg, A., Gupta, R., Aithal, N.H., Growth inhibition of B-cell precursor acute lymphoblastic leukaemia cell lines by monocytes: A role for prostaglandin E2 (1997) Leuk Res, 21 (10), pp. 925-932 | ||
| 504 | |a Geng, Y., Hellstrand, K., Wennmalm, A., Hanson, G.K., Apoptotic death of human leukaemic cells induced by vascular cells expressing nitric oxide synthase in response to γ-interferon and tumor necrosis factor-α (1996) Cancer Res, 56 (4), pp. 866-874 | ||
| 504 | |a Danforth, D.N., Sgagias, M., Tumor necrosis factor a enhances secretion of transforming growth factor β2 in MCF-7 breast cancer cells (1996) Clin Cancer Res, 2, pp. 827-835 | ||
| 504 | |a Bay, M.L., Rodelli, F.M., Mahuad, C.V., Morini, J.C., Inhibidores de la blastogénesis esplénica en cultives primarios de un sarcoma de rata (1998) Nuevas Tendencias en Oncología, 7 (1 SUPL). , abstract 8.13 | ||
| 504 | |a Voorzanger, N., Touitou, R., García, E., Delecluse, H.-J., Rousset, F., Joab, Y., Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and acts as cooperative growth factors (1996) Cancer Res, 56 (23), pp. 5499-5505 | ||
| 504 | |a Ladeda, V., Puricelli, L., Bal De Kier Joffé, E., Factores presentes en el órgano blanco de la metástasis aumentan la sobrevida de células tratadas con quimioterápicos (1998) Nuevas Tendencias en Oncología, 7 (1 SUPL). , Abstract 8.08 | ||
| 504 | |a Unanue, E., Allen, P., The basis for the immunoregulatory role of macrophages and other accesory cells (1987) Science, 236, p. 551 | ||
| 504 | |a Alfoldy, P., Lemmel, E., Uracz, W., Activation of human monocytes for nitroblue tetrazolium reduction and the suppression of lymphocyte response to mitogens (1979) Clin Exp Immunol, 41, p. 309 | ||
| 504 | |a Hedley, D., Currie, G., Monocytes and macrophages in malignant melanoma. Reduction of nitroblue tetrazolium by peripheral blood monocytes (1978) Br J Cancer, 37, p. 747 | ||
| 504 | |a García, M., Barañao, R., Fernández, O., Bordenave, R.H., Rumi, L.S., Circulating immune-complexes in breast and lung cancer, before and after chemotherapy (1987) Allergol et Immunopathol, 15, p. 15 | ||
| 504 | |a Novellino, P.S., Trejo, Y.G., Fernández, O., Bordenave, R.H., Rumi, L.S., Relación entre la expresión de HLA-DR de superficie y redución del NBT en monocitos de pacientes con cáncer colorrectal (1991) Sangre, 36, pp. 99-103 | ||
| 504 | |a Gruner, S., Volk, H., Falck, P., Von Baer, R., The influence of phagocytic stimuli on the expression of HLA-DR antigens; role of reactive oxigen metabolites (1986) Eur J Immunol, 16, p. 212 | ||
| 504 | |a Merendino, R., Generation of superoxide anion and candidacidal activity by LPS-treated macrophages from patients affected by neoplasia (1992) J Chemother, 4, p. 35 | ||
| 504 | |a Sztein, M.B., Johnson, H.M., Oppenheim, J.J., Regulation of human peripheral blood mononuclear cells DR antigen expression in vitro by lymphokines and recombinant interferons (1984) J Clin Invest, 73, pp. 565-665 | ||
| 504 | |a Chadban, S.J., Tesch, G.H., Foti, R., Lan, H.Y., Atkins, R., Nikolic-Paterson, D.J., Interleukin-10 differentially modulates MHC class II expression by mesangial cells and macrophages in vitro and in vivo (1998) Immunol, 94 (1), pp. 72-78 | ||
| 504 | |a Koppelman, B., Neefjes, J.J., De Vries, J.E., De Waal-Malefyt, R., Interleukin-10 down-regulates MHC class II alpha-beta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling (1997) Immunity, 7, pp. 861-871 | ||
| 504 | |a Huang, M., Sharma, S., Mao, J.T., Dubinett, S.M., Non-small cell lung cancer-derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production (1996) J Immunol, 157 (12), pp. 5512-5520 | ||
| 504 | |a Nicocia, G., Garipoli, C., Venza, M., Sottile, A., Pitini, V., Teti, D., Resistance to PGE2 inhibition of PWM-stimulated lymphocytes from neoplasic patients (1998) Clin Immunol Immunopathol, 87 (2), pp. 115-123 | ||
| 504 | |a Uracz, W., Stachura, J., Pituch, A., Popiela, T., Zembala, M., The altered expression of MHC-class II determinants on monocytes of cancer patients (1988) Cancer Immunol Immunother, 27, p. 171 | ||
| 520 | 3 | |a Background: it is well known that culture cells secrete to their medium different factors that can alter their own as well as other cells' metabolism and functions. In the present study we evaluated the effect of culture supernatants originated from two cancer cell lines, Calu-1 (lung epidermoid carcinoma) and A-427 (lung adenocarcinoma) on peripheral blood monocytes (MO) from 20 healthy donors (HD). Methods and results: MO were incubated with supernatants or with medium only (controls) during 2 or 18 hours. There were determined the expression of HLA-DR antigen by indirect immunofluorescence technique, the formation of reactive oxygen intermediates (NBT reduction capacity) and the phagocytic capacity (Candida albicans-anti Candida albicans system). These determinations were made also in MO from 16 patients with advanced lung cancer (LCP). Percentages of expression (media ± SE) were: HLA-DR (+) MO: Calu-1 = 30 ± 2; A-427 = 31 ± 2; LCP = 52 ± 3 (p < 0.0001 vs HD: 77 ± 1%) NBT (+)MO: Calu-1 = 47 ± 1; A-427 = 49 ± 1; LCP = 56 ± 2 (p < 0.01 vs HD: 45 ± 2%), Phagocytic MO: Calu-1 = 38 ± 3; A-427 = 39 ± 2; LCP = 32 ± 3 (p < 0.0001 vs HD: 50 ± 1%). Conclusions: we conclude that this in vitro model reproduced characteristics found in MO from lung cancer patients, since culture supernatants induced in normal MO phenotypic and functional characteristics also found in MO from patients analyzed. |l eng | |
| 593 | |a Laboratorio de Inmunología., Inst. de Biol. y Med. Exp. (IByME), Buenos Aires, Argentina | ||
| 593 | |a Inst. de Biol. y Med. Experimental, Vuelta de Obligado 2490, (1428) Buenos Aires, Argentina | ||
| 690 | 1 | 0 | |a CULTURE SUPERNATANTS |
| 690 | 1 | 0 | |a LUNG CANCER CELL LINES |
| 690 | 1 | 0 | |a MONOCYTES |
| 690 | 1 | 0 | |a HLA DR ANTIGEN |
| 690 | 1 | 0 | |a ARTICLE |
| 690 | 1 | 0 | |a CELL CULTURE |
| 690 | 1 | 0 | |a CULTURE MEDIUM |
| 690 | 1 | 0 | |a DRUG EFFECT |
| 690 | 1 | 0 | |a FLUORESCENT ANTIBODY TECHNIQUE |
| 690 | 1 | 0 | |a HUMAN |
| 690 | 1 | 0 | |a MONOCYTE |
| 690 | 1 | 0 | |a PHAGOCYTOSIS |
| 690 | 1 | 0 | |a SECRETION |
| 690 | 1 | 0 | |a CULTURE MEDIA, CONDITIONED |
| 690 | 1 | 0 | |a FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT |
| 690 | 1 | 0 | |a HLA-DR ANTIGENS |
| 690 | 1 | 0 | |a HUMANS |
| 690 | 1 | 0 | |a MONOCYTES |
| 690 | 1 | 0 | |a PHAGOCYTOSIS |
| 690 | 1 | 0 | |a TUMOR CELLS, CULTURED |
| 700 | 1 | |a Trejo, Y.G. | |
| 700 | 1 | |a Beviacqua, M. | |
| 700 | 1 | |a Bordenave, R.H. | |
| 700 | 1 | |a Rumi, L.S. | |
| 773 | 0 | |d 1999 |g v. 27 |h pp. 195-199 |k n. 4 |p Allergol. Immunopathol. |x 03010546 |t Allergologia et Immunopathologia | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033162341&partnerID=40&md5=af1847af28a69cf7d3cab706f71301c4 |y Registro en Scopus |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_03010546_v27_n4_p195_Novellino |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03010546_v27_n4_p195_Novellino |y Registro en la Biblioteca Digital |
| 961 | |a paper_03010546_v27_n4_p195_Novellino |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||